| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Rosalio Madrigal
Cynthia McLaughlin
Jenna Brashear
Jenna Brashear
| Share Statistics | WGS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,046.4 | $1,875.0 | 54% |
|
| Shares Out (Mil) | 29.3 | 77.1 | 37% |
|
| Institutional Ownership | 98.1% | 88.9% | 77% |
|
| Float (Mil) | 18.9 | 50.3 | 28% |
|
| Beta | 1.97 | 0.86 | 92% |
|
| Avg Daily Volume (000s) | 642 | 466 | 63% |
|
| Price Change (52-week) |
(24.9%) | 78.5% | 28% |
|
| Growth | WGS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 19.0% | 10.9% | 80% |
|
| Net Income (5yr) | 38.6% | (1.1%) | 90% |
|
| EPS (5yr) | na | 3.0% | na |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (18.2%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 8 | 8 | 8 | |
| Current EPS | ($0.188) | ($0.064) | $1.104 | |
| Month Ago EPS | ($0.188) | $0.110 | $1.231 | |
| # Rev Up | 2 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $0.116 | $0.912 | $2.057 | |
| Year/Year Chg | (91.3%) | (91.3%) | (327.1%) | |
| Financials | WGS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $443 | $1,464 | 40% |
|
| Net Income (TTM) (Mil) | ($78) | $15 | 13% |
|
| EPS (TTM) | ($2.689) | $0.300 | 12% |
|
| Operating Cash Flow (TTM) (Mil) | ($9) | $138 | 20% |
|
| Net Cash Flow (TTM) (Mil) | ($6) | $7 | 34% |
|
| Long-Term Debt (Q1) (Mil) | $163 | $323 | 48% |
|
| Enterprise Value (Q1) (Mil) | $1,668 | $2,130 | 47% |
|
| Valuation | WGS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 8.04 | 2.90 | 87% |
|
| P/E | na | 26.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | WGS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 69.6% | 27.6% | 81% |
|
| Net Margin | (17.6%) | 1.1% | 17% |
|
| ROA | (16.3%) | 1.8% | 22% |
|
| ROE | (30.4%) | 6.9% | 20% |
|
| Liabilities to Assets | 49.8% | 60.0% | 41% |
|
| F-Score | 3 | 5 | 19% |
|
GeneDx Holdings Corp. did not pass any screens on 7/30/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
